An observational study in Abdominal Neoplasm, sponsored by Xiangdong Cheng. Recruiting at 2 sites in China. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-26.
Sponsored by Xiangdong Cheng · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Abdominal Neoplasms with a site in China — 5 open to participants now, 5 under way, 1 of them phase 3. Abdominal Neoplasms · China.
Among the 10 studies in Abdominal Neoplasms with a site in China, this one is one of 3 that started in 2024, is one of 5 observational ones, and was the 7th registered.
42 studies on the registry are indexed under Abdominal Neoplasms; 14 are open to participants now.
Browse Abdominal Neoplasms studies →5 of the 10 studies in Abdominal Neoplasms with a site in China are open now. Recruiting first, the newest first:
The Children's Hospital of Zhejiang University School of Medicine · Sites in China
Ages 29 days–18 yrs
Sun Yat-sen University · Sites in China
Ages 18–70
Huazhong University of Science and Technology · Sites in China
Ages 18–85
Huazhong University of Science and Technology · Sites in China
Ages 18–85
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 8 Abdominal Neoplasms studies recruiting now, 4 set no upper age limit and 4 stop at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100,000 is above the median of 104 across 14 observational studies indexed under Abdominal Neoplasms.
Median enrollment 150 across the 5 interventional studies, 108 across the 5 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 9 most frequent:
Xiangdong Cheng is the lead sponsor of 7 studies on the registry; 6 are open to participants now.
Xiangdong Cheng has 1 study filed under Abdominal Neoplasms — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Abdominal Neoplasms with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Abdominal noncontrast scan and contrast-enhanced CT were used to establish a screening and diagnostic model for abdominal tumors
Secondary objective: To establish a grading model of abdominal tumors based on clinical indicators Exploratory Objective: To include CT scans in large-scale non-tumor populations for validation and to improve model accuracy Certainty
Patients with abdominal tumors or Non-tumor population
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Whether or not there is a diagnosis of abdominal tumor questionnaire
Whether or not there is a diagnosis of abdominal tumor
Time frame: first visited at baseline
Plan to share: Yes — Abdominal noncontrast scan and contrast-enhanced CT were used to establish a screening and diagnostic model for abdominal tumors
Supporting information: Study protocol
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Dec 2029, 65 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Xiangdong Cheng